Aclaris Therapeutics, Inc. ("Aclaris") is committed to providing support for Investigator-Initiated Studies (IIS).
The evaluation criteria include:
Aclaris IIS Committee will share further information following review of your concept proposal.
Our current areas of interest are dermatologic conditions such as: seborrheic keratosis; common warts; alopecia areata; and vitiligo.
If this is your first time applying for an IIS, please register by clicking on the "Register" button to the right. Otherwise, login to the IIS Portal using your username and password.
Please log in to the IIS Portal by entering your username and password in the fields below: (password is case-sensitive)